Skip to content
★ Sign in to follow
AP

Arthur Przybyl

CEO
ANI Pharmaceuticals IncAkorn Inc
Total declarations
132
Companies
2
▲ Purchases (2 ops.)
€116k
▼ Sales (16 ops.)
€13.9M

Latest filing published 08 Apr 2020 for ANI Pharmaceuticals INC, €131k.

Filing timeline

BuySale
Arthur Przybyl

Insider track record

Disclosed buys
2
Disclosed sells
16
Signal history

Closed purchases

Market purchases
2

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Arthur Przybyl: trading record in brief

Filings by Arthur Przybyl span 2 companies, the busiest being ANI Pharmaceuticals Inc and Akorn Inc. The record holds 132 filings, for trades running from 31 March 2006 to 7 April 2020.

The open-market side counts 2 purchases for €116k alongside 16 sales for €13.9M. The totals do not cover 1 filing with an undisclosed amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 84 share grants and 26 option exercises.

Most recently, on 8 April 2020, the filings show a share grant worth €85k in ANI Pharmaceuticals Inc. The clock since the last published purchase (12 November 2015) now reads 4,014 days. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Arthur Przybyl

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations132 total

25 of 132 declarations